CD19 and acute lymphoblastic leukemia: Despite this, some AATs are used as targets Despite the weak points on this approach; Currently, several approaches has been quite promising and help to open more studies exploring the full potential, for example: CD19-directed CAR-T therapy in acute lymphoblastic leukemia (ALL), which results in complete remission in a large number of patients [148].